1.
Vojinović T, Djuris J, Potpara Z, Ibric S. Oral lipid formulation type IV as an approach in the formulation of solid dosage forms with poorly soluble substances: Chremophor®RH 40 as a surfactant phase. Progr Nutr [Internet]. 2021 Oct. 7 [cited 2023 Jan. 29];23(3):e2021279. Available from: https://www.mattioli1885journals.com/index.php/progressinnutrition/article/view/12071